In a prospective, randomized, double-blind study, 40 patients undergoing gynaecological oncology surgery received either 0.1% ropivacaine with fentanyl 1 µg ml -1 or 0.2% ropivacaine with fentanyl 2 µg ml -1 . A PCEA pump was set to deliver ropivacaine 8 mg with fentanyl 8 µg with each successful demand and a lockout period of 15 min without background infusion. Patients were observed for rest and activity pain VAS, side effect incidence, peak expiratory flow rate (PEFR), leg strength, sensory block to cold and pinprick, and PCEA usage into the second postoperative day. Passive and active pain scores for both groups were both satisfactory and comparable for the duration of the study. There were no differences between groups with regard to side effects. There was a 24% increase in total drug used in the high-concentration/ low-volume group (PϽ0.05). The study demonstrated that PCEA ropivacaine with fentanyl is an effective means of postoperative analgesia for this patient population. Reduced drug consumption with high-volume/low-concentration solution confirms similar findings by other investigators using alternate local anaesthetic agents, and suggests that the therapeutic ratio of ropivacaine is widened if a low-concentration/high-volume solution is used. A combination of local anaesthetic with opioid by infusion of pulmonary function. Patient-controlled epidural analgesia into the epidural space provides effective postoperative (PCEA) allows the patient to relieve their postoperative analgesia for patients undergoing major abdominal pain 7 without interference by a subjective assessor. If gynaecological surgery, but not without risk of potentially analgesia is self-administered to provide comfort, then any lethal effects. 1 Ropivacaine is a local anaesthetic with an difference in total dose should be due to the composition epidural potency similar to bupivacaine 2 which displays of the analgesic solution. an improved cardiotoxicity profile 3 and reduced motor
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In a randomized, prospective, double blind manner, we block at doses which provide analgesia. 4 Without addi-compared the effects of concentration and volume on a tion of opioid, epidural 0.2% ropivacaine by infusion is ropivacaine-fentanyl mixture given epidurally for postconsidered the most effective concentration for postopera-operative analgesia in women who had undergone gynaecotive analgesia. 5 There is some evidence that a high-volume/ logical oncology laparotomy. low-concentration epidural (HVLC) solution is as effective as a low-volume/high-concentration (LVHC) solution for
Material and methods
relieving pain with less drug needed overall. 6 If this were Forty, ASA II-III women (20-79 yr, 40-120 kg) undergoing so, then administration of HVLC ropivacaine for epidural laparotomy with a combined general-epidural anaesthetic analgesia should provide an even greater margin of patient safety and also allow early mobilization with maintenance technique for ovarian, uterine or cervical cancer were epidural catheter placed via an 18-gauge Tuohy needle at a thoracic interspace (T 9/10 , T 10/11 or T 11/12 depending upon the proposed surgical incision) and advanced 5 cm inside the epidural space. Two 5-ml boluses of an epidural solution containing 0.2% ropivacaine with fentanyl 2 µg ml -1 were administered over 2 min, 5 min apart, followed by a
The pump and nursing chart displayed the dose of drug in milligrams delivered. Data were collected at 1, 4 and continuous infusion of the same solution at 8 ml h -1 (IMED Gemini PC-1, San Diego, CA, USA). A further bolus of 8 h after discharge from the recovery room, and then at 08:00, 12:00, 16:00 and 20:00 h on postoperative days 5 ml epidural solution was administered if haemodynamic data increased 20% above the baseline, and incre-1 and 2. Analgesia was assessed using a 10-cm visual analogue scale (VAS) at rest (passive pain score) and during ments of i.v. fentanyl and vecuronium were given as indicated. Crystalloid and colloid were administered performance of peak expiratory flow rate with the patient semi-reclined, and leg raising with patient flat (active pain together with 3-mg boluses of ephedrine to maintain mean arterial pressure within 20% of baseline values, and packed score). Sensory block to cold and pin prick was assessed together with muscle power (modified Oxford motor power cells were given intraoperatively when blood loss exceeded 10% of estimated blood volume (70 ml kg -1 ). At the end score 8 ). The incidence and severity of unwanted effects such as hypotension, nausea/vomiting, sedation and pruritus of the operative procedure, muscle relaxation was reversed with neostigmine and atropine.
were also assessed (Table 1) . PCEA data such as the number of boluses and attempts and total dose were downloaded In the recovery room, the epidural infusion was ceased and a PCEA device (Abbott Pain Management Provider directly via the RS232 serial port of the Abbott pump to a laptop computer at the completion of each study. Pump, Abbott Laboratories, North Chicago, IL, USA), programmed and primed with the trial solution by an A preliminary estimate of sample size was based on an expected 25% difference in dose requirements between the independent anaesthetist, was attached to the patient and education in the use of the device was reinforced. All HVLC and LVHC groups. With a type I error of 0.05 and a type II error of 0.2, the required sample size was 40 patients were block randomized to receive, in a double blinded manner, either 0.1% ropivacaine with fentanyl patients (Power Analysis & Sample Size for Windows PASS v.6.0, NCSS, Kaysville, UT, USA). Data were collated 1 µg ml -1 (HVLC) or 0.2% ropivacaine with fentanyl 2 µg ml -1 (LVHC) prepared by the Royal Brisbane Hospital using Excel 95 and statistical analysis performed using Arcus Quickstat (Biomedical) version 1.2 (Addison Wesley Central Pharmacy. The PCEA was programmed to deliver a bolus dose of ropivacaine 8 mg with fentanyl 8 µg (HVLC Longman, Cambridge 1998). Nominal data were analysed by unpaired t-test while VAS data were analysed by Manngroup received an 8-ml bolus on successful demand and the LVHC group a 4-ml bolus), with a 15-min lockout Whitney U-testing. A value of PϽ0.05 was considered significant. period and without any background infusion. 
Results
Of the 40 patients enrolled, four (two in each group) required conversion to alternate analgesia to provide satisfactory pain relief and were excluded from analysis. Both groups were comparable with respect to age, height, weight, duration of surgery and blood loss ( Table 2 ). The HVLC group had a slightly greater proportion of ASA III patients, and two patients in this group had full midline incisions as opposed to none in the LVHC group. Both the HVLC and LVHC groups had low median VAS scores during both passive pain (resting) and active pain, with no difference between the groups (Fig. 1) . Pain scores were generally higher with PEFR measurement compared to Oxford power assessment, but the difference did not reach significance except at a single time point (20:00 h postoperative day 1, Pϭ0.033, CI 1-30).
Each study duration varied depending on the time of discharge of the patient from recovery (mean HVLC 53.75 h, LVHC 54.32 h) and ranged from a minimum of HVLC group ropivacaine consumption to be significantly less than the LVHC group (Pϭ0.03, CI 0.22-3.88).
The scores for nausea/vomiting, sedation, pruritus and a 30% decrease by postoperative day 2 ( Table 2 ). There were no differences between groups and inter-patient modified Oxford on each day were averaged, and daily averaged data compared between groups (Fig. 2) . Both variability was marked. Modified Oxford scores demonstrated full return of quadriceps strength by the first postnausea/vomiting and sedation scores were high on the day of surgery for both groups (2 and 1.9 for the HVLC group operative day with minimal weakness on the day of surgery, and no difference between the groups. and 1.75 and 2 for the LVHC group, respectively) and progressively declined over the next 2 days. Pruritus scores There was no significant difference between the groups in sensory block assessment at any stage. Median block were low throughout the study period. There were no differences between the groups for any of the assessed spread decreased with time (Table 3) . However, sensory block varied markedly between patients and in the individual effects.
Both groups showed~40% decrease in PEFR from the patient over time. Two patients in each group had no demonstrable block or pain on postoperative day 2. baseline on the first postoperative day, which improved to
Fig 2
Unwanted effect score (sed ϭ sedation, n/v ϭ nausea and vomiting, itch ϭ pruritus, oxford ϭ muscle power) for the 0.1% and 0.2% ropivacaine groups at the measurement times (D0 ϭ day of operation, D1 ϭ first postoperative day, D2 ϭ second postoperative day). There were no significant differences between the groups at any of the measurement times. Data are mean (histogram) and SD (error bars). may be a reflection of the small amount of fentanyl utilized by either group. Lower limb motor block was minimal and was only apparent on the day of surgery. All patients were
Discussion
able to stand unassisted on the first postoperative day and Treating postoperative pain following gynaecological none of the patients who demonstrated more extensive oncology surgery with patient-controlled epidural analgesia sensory block on postoperative days 1 and 2 showed using low-concentration ropivacaine (0.1%) with low-dose any demonstrable leg weakness, lending support to the fentanyl (1 µg ml -1 ) appears satisfactory. This study showed proposition that ropivacaine produces a differential nerve a significant reduction in the dose of the drug used to block at low concentrations. 4 The reductions in PEFR in provide equal analgesia when the solution was high volume, this study are comparable with others using a combined low concentration compared with low volume, high con-epidural-general anaesthetic technique for abdominal centration, thereby potentially increasing the margin surgery. 14 There was no difference in PEFR reduction or between therapeutic and toxic drug levels. These findings the maximum upper sensory level of the epidural block are in accord with other workers. 8 9 In this study, active achieved between the groups, supporting the view that pain scores showed a good level of analgesia with the lower epidural block spread is dose, rather than volume concentration of ropivacaine. This is contrary to the findings dependent. 4 10 of several workers, but their data were collected without Epidural analgesia had to be aborted in 10% of patients the addition of epidural opioid. 4 5 10 It is hypothesized that during the study, which is comparable to the efficacy failure more painful stimuli penetrate an anaesthetic sleeve at lower rate of epidural infusions of bupivacaine with fentanyl. 1 local anaesthetic concentrations, thereby failing to provide Two patients developed a unilateral block and two patients adequate pain relief on movement and coughing. 11 12 bilateral block failure. Complete block failure was evident The incidence and severity of nausea/vomiting and on the first postoperative day despite there being adequate analgesia and sensory block on the day of surgery. sedation was high on the day of surgery. This is expected after major lower abdominal surgery -a dose finding study. Anesth Tachyphylaxis is considered a possible cause, there being 
